Roundtable Discussion: Exploring Future Opportunities for Radioligand Therapy Moiety Engineering to Optimize Therapeutic Activity
- What moiety features most strongly drive tumor selectivity and residence time?
- How can radionuclide–moiety pairing be tuned to match tumor biology and dosimetry goals?
- How can imaging and modeling data be used to guide moiety optimization?